Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P36639
UPID:
8ODP_HUMAN
Alternative names:
2-hydroxy-dATP diphosphatase; 7,8-dihydro-8-oxoguanine triphosphatase; 8-oxo-dGTPase; Methylated purine nucleoside triphosphate hydrolase; Nucleoside diphosphate-linked moiety X motif 1
Alternative UPACC:
P36639; A4D205; Q6LES7; Q6P0Y6; Q7Z7N6; Q8IV95; Q9UBM0; Q9UBM9
Background:
Oxidized purine nucleoside triphosphate hydrolase, known by alternative names such as 2-hydroxy-dATP diphosphatase and 8-oxo-dGTPase, plays a crucial role in maintaining the integrity of the DNA. It sanitizes the nucleotide pool by hydrolyzing oxidized purine nucleosides, thus preventing their incorporation into DNA and averting potential mutations.
Therapeutic significance:
Understanding the role of Oxidized purine nucleoside triphosphate hydrolase could open doors to potential therapeutic strategies. Its ability to prevent the integration of damaged nucleotides into DNA highlights its significance in maintaining genomic stability, a cornerstone in the prevention and treatment of various genetic disorders.